Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.71 |
| ▸ | IDO1 | P14902 | 3/20 | 0.62 |
| ▸ | PNMT | P11086 | 1/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.58 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.56 |
| ▸ | HTR3B | O95264 | 1/20 | 0.56 |
| ▸ | HTR3A | P46098 | 1/20 | 0.56 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.56 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.56 |
| ▸ | DAO | P14920 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10537178 | 0.87 | TAAR1 (0.58) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL1822278 | 0.86 | TAAR1 (0.62) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL575128 | 0.86 | TAAR1 (0.62) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL20861010 | 0.85 | TAAR1 (0.56) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL8706198 | 0.85 | TAAR1 (0.56) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL838926 | 0.84 | TAAR1 (0.60) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL320795 | 0.84 | TAAR1 (0.60) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL266281 | 0.84 | TAAR1 (1.00) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL1674574 | 0.84 | TAAR1 (0.60) | TAAR1IDO1PNMTSLC6A2SLC6A4 | |
| SCHEMBL7432386 | 0.84 | TAAR1 (0.60) | TAAR1IDO1PNMTSLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559466-B2 | Process for preparation of intermediates | UPL LTD (IN) | 2026-02-24 | — | — | US | claimed |
| EP-4385329-A2 | IMPROVED PROCESS FOR PREPARATION OF INTERMEDIATES | UPL Ltd (IN) | 2024-06-19 | — | — | EP | claimed |
| CN-112399967-A | Improved process for the preparation of intermediates | UPL有限公司 | 2021-02-23 | — | — | CN | claimed |
| EP-3762356-A1 | IMPROVED PROCESS FOR PREPARATION OF INTERMEDIATES | UPL Ltd (IN) | 2021-01-13 | — | — | EP | claimed |
| US-20200399236-A1 | IMPROVED PROCESS FOR PREPARATION OF INTERMEDIATES | UPL LTD (IN) | 2020-12-24 | — | — | US | claimed |
| WO-2019171161-A1 | IMPROVED PROCESS FOR PREPARATION OF INTERMEDIATES | UPL LTD (IN) | 2019-09-12 | — | — | WO | claimed |
| US-12559466-B2 | Process for preparation of intermediates | UPL LTD (IN) | 2026-02-24 | — | — | US | disclosed |
| EP-4385329-A2 | IMPROVED PROCESS FOR PREPARATION OF INTERMEDIATES | UPL Ltd (IN) | 2024-06-19 | — | — | EP | disclosed |
| US-11129827-B2 | Dual MAGL and FAAH inhibitors | ABIDE THERAPEUTICS, INC. (US) | 2021-09-28 | — | — | US | disclosed |
| CN-112399967-A | Improved process for the preparation of intermediates | UPL有限公司 | 2021-02-23 | — | — | CN | disclosed |
| US-20200399236-A1 | IMPROVED PROCESS FOR PREPARATION OF INTERMEDIATES | UPL LTD (IN) | 2020-12-24 | — | — | US | disclosed |
| US-20200399236-A1 | IMPROVED PROCESS FOR PREPARATION OF INTERMEDIATES | UPL LTD (IN) | 2020-12-24 | — | — | US | disclosed |
| US-20190282568-A1 | DUAL MAGL AND FAAH INHIBITORS | LUNDBECK LA JOLLA RESEARCH CENTER, INC. | 2019-09-19 | — | — | US | disclosed |
| US-6686428-B2 | TRANSMETALLATION REAGENTS REACTED WITH ALPHA-HALOCARBONYL COMPOUNDS IN THE PRESENCE OF A METAL CATALYST | THE PENN STATE RESEARCH FOUNDATION | 2004-02-03 | — | — | US | disclosed |
| US-20020193543-A1 | Transmetallation reagents reacted with alpha-halocarbonyl compounds in the presence of a metal catalyst | NATIONAL INSTITUTES OF HEALTH | 2002-12-19 | — | — | US | disclosed |
| EP-0415247-B1 | Process for the preparation of ether solutions of arylmethylmagnesium halides | BASF AG (DE) | 1995-10-25 | — | — | EP | disclosed |
| US-5093046-A | Suppression of dimerization | BASF AKTIENGESELLSCHAFT (DE) | 1992-03-03 | — | — | US | disclosed |
| EP-0415247-A2 | Process for the preparation of ether solutions of arylmethylmagnesium halides | BASF Aktiengesellschaft (DE) | 1991-03-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559466-B2 | Process for preparation of intermediates | CBR1, POR, CYP2E1 | TAAR1 500/4885IDO1 321/4885PNMT 445/4885 |
| US-11129827-B2 | Dual MAGL and FAAH inhibitors | FAAH, FAAH2, MAG | TAAR1 284/4885IDO1 1230/4885PNMT 578/4885 |
| US-20200399236-A1 | IMPROVED PROCESS FOR PREPARATION OF INTERMEDIATES | OGDH, OXGR1, POR | TAAR1 721/4885IDO1 528/4885PNMT 465/4885 |
| US-20190282568-A1 | DUAL MAGL AND FAAH INHIBITORS | FAAH, FAAH2, MAG | TAAR1 284/4885IDO1 1230/4885PNMT 578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.